APA (7th ed.) Citation

S, S., ZM, S., D, R., D, Z., A, N., D, F., . . . R, J. (2025). Imlunestrant a next-generation oral SERD overcomes ESR1 mutant resistance in estrogen receptor-positive breast cancer. JCI insight, 10(12), . https://doi.org/10.1172/jci.insight.188051

Chicago Style (17th ed.) Citation

S, Sherman, et al. "Imlunestrant a Next-generation Oral SERD Overcomes ESR1 Mutant Resistance in Estrogen Receptor-positive Breast Cancer." JCI Insight 10, no. 12 (2025). https://doi.org/10.1172/jci.insight.188051.

MLA (9th ed.) Citation

S, Sherman, et al. "Imlunestrant a Next-generation Oral SERD Overcomes ESR1 Mutant Resistance in Estrogen Receptor-positive Breast Cancer." JCI Insight, vol. 10, no. 12, 2025, https://doi.org/10.1172/jci.insight.188051.